NCT00473668View on ClinicalTrials.gov

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 1, 2007

Primary Completion Date

January 30, 2008

Study Completion Date

January 30, 2008

Conditions
Whole Cell PertussisHaemophilus Influenzae Type bTetanusDiphtheriaHepatitis B
Interventions
BIOLOGICAL

Zilbrix-Hib

Intramuscular injection, 1 dose

BIOLOGICAL

Tritanrix™-HepB/ Hiberix™

Intramuscular injection, 1 dose

Trial Locations (3)

221005

GSK Investigational Site, Varanasi

560034

GSK Investigational Site, Bangalore

700072

GSK Investigational Site, Kolkotta

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY